PRF1 and cancer: However, responders had an increase in CD8, GZMA and PRF1 expression levels compared to non-responders (Figure 4D), implying that cytolytic T lymphocytes with high cytotoxic activity were strongly infiltrated, expanded, and activated in cancer tissues by dual blockade in responders and TNBC patients.